Stewart B. Fleishman

21.4k total citations · 3 hit papers
40 papers, 15.0k citations indexed

About

Stewart B. Fleishman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stewart B. Fleishman has authored 40 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Stewart B. Fleishman's work include Cancer survivorship and care (10 papers), Cancer Treatment and Pharmacology (9 papers) and Palliative Care and End-of-Life Issues (5 papers). Stewart B. Fleishman is often cited by papers focused on Cancer survivorship and care (10 papers), Cancer Treatment and Pharmacology (9 papers) and Palliative Care and End-of-Life Issues (5 papers). Stewart B. Fleishman collaborates with scholars based in United States, France and Lebanon. Stewart B. Fleishman's co-authors include Sam H. Ahmedzai, S Schraub, N. Duez, Monika Bullinger, A. Cull, Marianne Sullivan, David Osoba, A. Filiberti, S. Kaasa and Bengt Bergman and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Stewart B. Fleishman

38 papers receiving 14.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 11.9k citations N.K. Aaronson, Sam H. Ahmedzai et al. JNCI Journal of the National Cancer Institute profile →
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy

2013 718 citations Elizabeth Smith, Herbert Pang et al. JAMA profile →
Screening for psychologic distress in ambulatory cancer patients

2005 669 citations Stewart B. Fleishman, Jimmie C. Holland et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stewart B. Fleishman United States	23	9.0k	4.6k	2.9k	2.8k	2.2k	40	15.0k
Bengt Bergman Sweden	31	9.6k 1.1×	5.6k 1.2×	3.0k 1.0×	2.5k 0.9×	2.1k 0.9×	101	16.1k
Hans‐Henning Flechtner Germany	34	8.9k 1.0×	4.4k 1.0×	3.0k 1.0×	2.9k 1.0×	2.1k 0.9×	117	15.2k
M. Klee Denmark	16	8.5k 0.9×	3.9k 0.9×	2.9k 1.0×	2.4k 0.9×	1.9k 0.9×	23	13.9k
N.K. Aaronson Netherlands	13	7.6k 0.8×	4.4k 1.0×	2.7k 0.9×	2.3k 0.8×	1.9k 0.8×	25	13.4k
K.C.A. Sneeuw Netherlands	14	7.9k 0.9×	4.0k 0.9×	2.9k 1.0×	2.4k 0.8×	2.0k 0.9×	17	13.7k
S. Kaasa Norway	7	7.3k 0.8×	3.6k 0.8×	2.6k 0.9×	2.2k 0.8×	1.7k 0.8×	15	12.2k
A. Filiberti Italy	14	7.6k 0.8×	3.7k 0.8×	2.8k 0.9×	2.2k 0.8×	1.8k 0.8×	26	12.6k
Sam H. Ahmedzai United Kingdom	40	9.1k 1.0×	4.6k 1.0×	3.3k 1.1×	3.4k 1.2×	4.0k 1.8×	150	18.0k
S Schraub France	35	8.8k 1.0×	4.9k 1.1×	3.5k 1.2×	2.3k 0.8×	1.9k 0.8×	110	16.4k
N. Duez Belgium	24	8.7k 1.0×	4.5k 1.0×	4.1k 1.4×	2.2k 0.8×	1.7k 0.8×	49	14.4k

Countries citing papers authored by Stewart B. Fleishman

Since Specialization

Citations

This map shows the geographic impact of Stewart B. Fleishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stewart B. Fleishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stewart B. Fleishman more than expected).

Fields of papers citing papers by Stewart B. Fleishman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stewart B. Fleishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stewart B. Fleishman. The network helps show where Stewart B. Fleishman may publish in the future.

Co-authorship network of co-authors of Stewart B. Fleishman

This figure shows the co-authorship network connecting the top 25 collaborators of Stewart B. Fleishman. A scholar is included among the top collaborators of Stewart B. Fleishman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stewart B. Fleishman. Stewart B. Fleishman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleishman, Stewart B., et al.. (2023). Acupuncture Reduces Severity of Hot Flashes in Breast Cancer. Holistic Nursing Practice. 37(6). 330–336. 1 indexed citations

Smith, Elizabeth, Herbert Pang, Constance Cirrincione, et al.. (2015). Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. European Journal of Cancer Care. 26(2). e12421–e12421. 45 indexed citations

Smith, Elizabeth, Herbert Pang, Constance Cirrincione, et al.. (2013). Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy. JAMA. 309(13). 1359–1359. 718 indexed citations breakdown →

Smith, Elizabeth, Herbert Pang, Constance Cirrincione, et al.. (2012). CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).. Journal of Clinical Oncology. 30(15_suppl). CRA9013–CRA9013. 10 indexed citations

Carper, Elise, et al.. (2012). Outcomes of Guided Imagery in Patients Receiving Radiation Therapy for Breast Cancer. Clinical journal of oncology nursing. 16(6). 617–623. 20 indexed citations

Fleishman, Stewart B., et al.. (2012). Prevalence of Delayed Nausea and/or Vomiting in Patients Treated With Oxaliplatin-Based Regimens for Colorectal Cancer. Journal of Oncology Practice. 8(3). 136–140. 7 indexed citations

Breuer, Brenda, Stewart B. Fleishman, Ricardo A. Cruciani, & Russell K. Portenoy. (2011). Medical Oncologists' Attitudes and Practice in Cancer Pain Management: A National Survey. Journal of Clinical Oncology. 29(36). 4769–4775. 170 indexed citations

Kligler, Benjamin, et al.. (2011). Impact of the Urban Zen Initiative on Patients' Experience of Admission to an Inpatient Oncology Floor: A Mixed-Methods Analysis. The Journal of Alternative and Complementary Medicine. 17(8). 729–734. 22 indexed citations

Campbell, Amy T., et al.. (2010). How Bioethics Can Enrich Medical-Legal Collaborations. The Journal of Law Medicine & Ethics. 38(4). 847–862. 9 indexed citations

10.

Fleishman, Stewart B., Hina Khan, Peter Homel, et al.. (2010). Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens. Journal of Clinical Oncology. 28(34). 5054–5060. 25 indexed citations

11.

Lower, Elyse E., Stewart B. Fleishman, Jerome B. Zeldis, et al.. (2009). Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical Trial. Journal of Pain and Symptom Management. 38(5). 650–662. 137 indexed citations

12.

Dresler, Carolyn M., Jemi Olak, James E. Herndon, et al.. (2005). Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion. CHEST Journal. 127(3). 909–915. 376 indexed citations

13.

Cruciani, Ricardo A., Peter Homel, B. Culliney, et al.. (2004). l‐Carnitine Supplementation for the Treatment of Fatigue and Depressed Mood in Cancer Patients with Carnitine Deficiency: A Preliminary Analysis. Annals of the New York Academy of Sciences. 1033(1). 168–176. 69 indexed citations

14.

Fleishman, Stewart B.. (2004). Treatment of Symptom Clusters: Pain, Depression, and Fatigue. JNCI Monographs. 2004(32). 119–123. 63 indexed citations

15.

Harkness, Janet, Richard M. Frankel, Debra Roter, et al.. (2000). Involving family members in cancer care: focus group considerations of patients and oncological providers. Psycho-Oncology. 9(2). 101–112. 68 indexed citations

16.

Herndon, James E., Stewart B. Fleishman, Alice B. Kornblith, et al.. (1999). Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?. Cancer. 85(2). 333–340. 176 indexed citations

17.

Fleishman, Stewart B. & Thomas B. Strouse. (1998). Foreword. Psycho-Oncology. 7(4). 283–284. 1 indexed citations

18.

Herndon, James E., Stewart B. Fleishman, Michael P. Kosty, & Mark R. Green. (1997). A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931. Controlled Clinical Trials. 18(4). 286–300. 27 indexed citations

19.

Aaronson, N.K., Sam H. Ahmedzai, Bengt Bergman, et al.. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. JNCI Journal of the National Cancer Institute. 85(5). 365–376. 11859 indexed citations breakdown →

20.

Lesko, Lynna M. & Stewart B. Fleishman. (1991). Treatment and Support in Confusional States. Recent results in cancer research. 121. 378–392. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact